In 1997, ZEISS was the first company to introduce optical coherence tomography (OCT) for clinical use in ophthalmology and optometry. This technology, which assists doctors in the diagnosis and management of many serious eye diseases, has become the standard of care in ophthalmic imaging.
With ZEISS's dedication to ongoing research and development of OCT, the earlier time domain OCT technology rapidly evolved to deliver high-definition spectral domain images and broader clinical applications. Recent developments include new applications for AMD and glaucoma as well as integration with HFA™ in the ZEISS FORUM® Glaucoma Workplace.
ZEISS also offers several different models of CIRRUS™ OCT to accommodate the varying patient population, budgets and workflow of practices and hospitals worldwide.